Multiphoton Microscopy for Ophthalmic Imaging by Gibson, Emily A. et al.
Hindawi Publishing Corporation
Journal of Ophthalmology
Volume 2011, Article ID 870879, 11 pages
doi:10.1155/2011/870879
Review Article
MultiphotonMicroscopy forOphthalmicImaging
EmilyA.Gibson,1 OmidMasihzadeh,2,3 TimC.Lei,2 DavidA.Ammar,3 andMalikY.Kahook3
1Department of Bioengineering, University of Colorado Denver, Denver, 12700 E. 19th Ave, Mail Stop 8607,
Aurora, CO 80045, USA
2Department of Electrical Engineering, University of Colorado Denver, Denver, CO 80217, USA
3Department of Ophthalmology, School of Medicine, University of Colorado, 1675 Aurora Ct, Mail Stop F-731,
Aurora, CO 80045, USA
Correspondence should be addressed to Malik Y. Kahook, malik.kahook@gmail.com
Received 5 July 2010; Revised 6 September 2010; Accepted 26 October 2010
Academic Editor: Christopher Leung
Copyright © 2011 Emily A. Gibson et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
We review multiphoton microscopy (MPM)including two-photon autoﬂuorescence (2PAF), second harmonicgeneration (SHG),
third harmonic generation (THG), ﬂuorescence lifetime (FLIM), and coherent anti-Stokes Raman Scattering (CARS) with
relevance to clinical applications in ophthalmology. The diﬀerent imaging modalities are discussed highlighting the particular
strength thateach has forfunctional tissueimaging.MPM is compared with current clinicalophthalmologicalimagingtechniques
such as reﬂectance confocal microscopy, optical coherence tomography, and ﬂuorescence imaging. In addition, we discuss the
future prospects for MPM in disease detection and clinical monitoringof disease progression,understanding fundamentaldisease
mechanisms,and real-time monitoring of drug delivery.
1.Introduction
Imaging modalities such as digital photography and ultra-
s o u n dh a v eb e c o m ei n t e g r a li nt h ec l i n i c a la n ds u r g i c a l
practice of ophthalmology over the past few decades. More
recently, diode laser-based imaging devices such as GDx
(Carl Zeiss Meditec, Inc., Dublin, CA), Heidelberg Retinal
Tomography (HRT, Heidelberg Engineering, Heidelberg,
Germany), and optical coherence tomography (OCT) have
become invaluable in the examination and early diagnosis
of disease ranging from macular degeneration to glaucoma.
Despite these advances, the aforementioned imaging devices
are restricted in their ability to image tissue structure while
being largely unable to elucidate tissue function. This limi-
tation becomes even more important when noting that the
structural normative databases used to delineate abnormal
from normal tissue have inherent limitations. Physiologic
diﬀerences from patient to patient as well as coexisting
conditions, such as possible thinning of the retinal nerve
ﬁber layer (RNFL) in high myopia, may alter the structure
of tissues but often do not alter actual visual function [1].
An imaging modality that could combine both structural
and functional imaging would allow physicians to make
more informed decisions that directly relate to disruptions
in visual performance.
Multiphoton microscopy (MPM) has found increasing
use in laboratory-based biomedical imaging due to its
subcellular resolution along with the ability to obtain
structural and functional information. These properties
make MPM unique compared to other imaging modalities
such as ultrasound, magnetic resonance imaging (MRI),
or X-ray/computed tomography (CT) imaging. However,
to achieve these beneﬁts, there is a drawback in the
limited tissue penetration depth as well as the ability to
image highly scattering tissues such as sclera. Fortunately,
there are opportunities for using optical imaging in the
eye because of the transparency of the cornea, lens, and
vitreous humor to visible and infrared light. In this paper,
we review current research on MPM imaging of the eye
and discuss future possibilities for applications to early
disease diagnosis and monitoring of patient treatment
outcomes.2 Journal of Ophthalmology
2.MultiphotonMicroscopy:
Theoryand Implementation
2.1. Overview of Multiphoton Microscopy. Multiphoton
microscopy has been described in depth in many review
articles and texts [2–7]. Here, we highlight some of the
key features of MPM that would have application in
clinical in vivo measurements. MPM is an imaging method
based on nonlinear optical response of a medium, that is,
processes that involve more than one photon interacting
simultaneously with a molecule. Since the probability of
simultaneous interactions with two (or more) photons is
extremely low (cross-sections on order of 10−50 cm4 so r
1GM), the process only occurs when there is high photon
ﬂux (on the order of 106–108 W/cm2)[ 2, 8]. This is typically
achieved using a pulsed near-infrared laser with a pulse
d u r a t i o no no r d e ro f∼100 femtoseconds focused with a
high numerical aperture objective. As a result, MPM oﬀers
intrinsic axial cross-sectioning because the process only
occurs at the focus of the microscope objective, where the
laser intensity is greatest. MPM imaging oﬀers equivalent
resolutionasconfocalmicroscopy(∼200nmlateraland ∼1.0
micronaxial)butdoesnotrequiretheuseofapinhole.Image
acquisition times are similar to confocal microscopy, with
an image of 256 × 256 pixels acquired at video rate. The
acquisition time is comparable to OCT with a diﬀerence in
that MPM provides subcellular resolution within a smaller-
imaged region while OCT scans over a larger area with
reducedresolution.Itisimportant torealize, forapplications
in medicine, that MPM can provide contrast without
exogenous dye labeling and is a completely noninvasive
technique.
An additional advantage of using a near-infrared laser
source is deeper tissue penetration due to reduced light
scattering with longer wavelengths of light. The imaging
depthpossible dependsuponthetypeoftissue andthe wave-
length of the laser. Imaging depths of up to 1mm have been
reported in brain tissue by using higher laser powers from
a Ti:sapphire regenerative ampliﬁer at 800nm [9]. More
sophisticated methods for deeper image penetration employ
adaptivewavefrontcorrection,similartothetechnologyused
by astronomers in ground-based telescopes. Analogous to
the distortion of the image quality due to the atmosphere,
in deep tissue MPM, the local inhomogeneities in refractive
index in tissue distort the focus of the excitation laser,
causing a reduction in signal. A deformable mirror or spatial
light modulator can be incorporated before the objective
to precompensate for the wavefront distortion leading to a
diﬀraction-limited focal spot size in tissue depths of 500μm
[10–12].
MPM includes two-photon excitation ﬂuorescence
(2PEF), second harmonic generation (SHG), and third
harmonic generation (THG), as well as coherent anti-Stokes
Raman Scattering (CARS) described in a later section.
Figure 1 shows a schematic of the diﬀerent processes that
result from nonlinear multiphoton interactions with a
molecule. 2PEF is very similar to traditional ﬂuorescence,
exceptthat two photonsofa lowerenergy are simultaneously
absorbedtoexciteaﬂuorophore.When2PEFisusedtoexcite
Table 1: Optimal imaging contrast mechanism for diﬀerent
biological molecules.
Compound Imaging technique (excitation/emission
wavelengths)
NAD(P)H 2PAF/FLIM (excitation 700–730nm/emission
peak 460nm) [16]
FAD 2PAF/FLIM (excitation 700–900nm/emission
peak 525nm) [16]
Elastin 2PAF (excitation 700–740nm/emission peak
400nm) [15, 19]
Collagen SHG (SHG excitation is tunable/emissionat
one-half the excitation wavelength) [15]
Lipids
THG/CARS (THG excitation is tunable with
emission at one-third the excitation wavelength)
[14]
endogenous ﬂuorophores such as elastin and NAD(P)H, it
is typically called two-photon excitation autoﬂuorescence
(2PAF). A ﬂuorophore is any molecule that can absorb
photons and emit the energy as a photon with a red-
shifted wavelength. Another nonlinear process that occurs
with two-photon excitation is second harmonic generation
(SHG). SHG can only occur when light interacts with
noncentrosymmetric (asymmetric) macromolecular struc-
tures. Molecules such as collagen ﬁbers can simultaneously
“scatter” two lower-energy photons as a single photon of
twice the energy. Third harmonic generation is analogous to
SHG;however,inthis case,threephotonsofthefundamental
are upconverted to a single photon of three times the energy.
THG only requires about ten times the photon ﬂux as
SHG and, therefore, can be a useful tool for imaging. THG
highlights diﬀerent features of a sample than SHG because
it is generated at the interface of media with diﬀering third-
order nonlinear susceptibilities, χ(3) [13, 14].
Endogenous ﬂuorophores have varying two-photon
cross-sections as a function of wavelength and have been
measured and reported [15, 16]. The center wavelength
of a Ti:spphire laser can be tuned over a large spectral
range from 700 to 1050nm, making it an extremely useful
source for two-photon autoﬂuorescence excitation. In this
manner, diﬀerent compounds in tissue can be highlighted
by tuning the excitation wavelength. For example, the two-
photon cross-sections of many endogenous ﬂuorophores
peak below 700nm and decrease at higher wavelengths,
while SHG emission remains strong at longer wavelengths
from 900 to 1000nm [15]. By tuning the excitation laser
to longer wavelengths, collagen structures in tissue can be
distinguished from autoﬂuorescence [17, 18]. In another
example of the utility of excitation wavelength tuning,
NAD(P)H was distinguished from FAD by dual wavelength
excitation at 730nm (where both compounds are excited)
and at 900nm (where FAD is exclusively excited, while
NAD(P)H has a negligible two-photon cross-section) [16].
Table 1 gives a list of endogenous ﬂuorophores and tissue
structures and the imaging technique that provides the best
contrast mechanism.Journal of Ophthalmology 3
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Figure 1: Jablonski diagram showing the interaction of multiple infrared photons with the electronic and vibrational energy levels of a
molecule. (a) In two-photon excitation ﬂuorescence (2PEF), the molecule absorbs two infrared photons that promote it to the excited
electronic state. After relaxation to a lowervibrational level, the molecule emits a lower energy (red-shifted) photon. (b) In second harmonic
generation (SHG), two infrared photons are instantaneously upconverted to a single photon of twice the energy. (c) In third harmonic
generation (THG), three infrared photons are instantaneously upconverted to a single photon of thrice the energy. (d) In Coherent anti-
Stokes Raman Scattering (CARS), two photons with energies hνp and hνs coherently excite the vibrational level with energy hΩ = hνp −hνs.
An additional photon, hνp, interacts with the vibrationally excited molecule emitting a photon with energy given by the original incident
photon energy plus the vibrational energy, hνCARS = hνp +hΩ, leaving the molecule in its originalground state. (Note that photon energy is
given by Planck’sconstant, h, multiplied by the frequency of the photon ν.)4 Journal of Ophthalmology
2.2. Optical Instrumentation. Both 2PAF and SHG can be
simultaneously measured using the same optical setup since
the SHG signal occurs at a distinct wavelength (exactly
half the excitation wavelength) and can be separated from
autoﬂuorescence using spectral ﬁltering. Figure 2 shows a
schematic of a typical setup for performing MPM. The
apparatus consists of a pulsed femtosecond infrared laser
source, typically Ti:sapphire mode-locked oscillator. The
excitationlightﬁrstpassesthroughatwo-axisgalvo-scanning
mirror stage and is imaged, using a scan lens and a tube lens,
on to the back of the microscope objective. The microscope
objective focuses the light to a focal volume typically around
200nm axial and 1.0 microns lateral (depending upon the
numerical aperture of the objective). The excitation volume
is on order of a femtoliter (10−15 L). The generated two-
photon signal is collected back through the same objective
and separated from the excitation light using a dichroic
mirror and ﬁlter. It is then imaged onto the front of a
photomultiplier tube (PMT). In descanned detection, the
multiphoton emission is relayed back through the galvo
mirrors so that the scanning motion is cancelled out and the
emitted light is stationary at the detector. In nondescanned
detection, the emission light is separated using a dichroic
mirror without passing through the scanning mirrors greatly
reducing the loss in signal associated with reﬂections oﬀ of
the mirrors and the lenses in the optical path. Because the
two-photon emission is not passed back through the scan-
ning mirrors, the emission light on the PMT moves during
scanning; however, the PMT is typically insensitive to this
motion because of its large detection area. Nondescanned
detection is available only for multiphoton imaging because,
unlike in single-photon confocal imaging, a pinhole is not
required to eliminate out-of-focus light from the image.
2.3. Advanced Multiphoton Microscopy Techniques. Fluores-
cence lifetime imaging microscopy (FLIM) is an additional
imaging technique that is better able to distinguish between
thediﬀerentendogenousﬂuorophoresinabiologicalsample.
Due to the broad and overlapping emission spectra of many
endogenous ﬂuorophores, it is diﬃcult to quantitatively
measure the concentrations of these diﬀerent species con-
tributing to the autoﬂuorescence emission signal by spectral
ﬁltering alone. Fluorescence lifetime can also provide infor-
mation on the surrounding environment of the ﬂuorophore.
FLIM is based on the fact that every ﬂuorophore has a char-
acteristic excited-state lifetime, τ, or time for the molecule
to decay from the excited electronic state to the ground
state. This decay is characterized by a single or multiple
exponential (in the case of an inhomogeneous environment)
of the form P(t) = P0
n
i=1 Ai exp(−t/τi), where P(t)i st h e
population in the excited state as a function of time. Here,
P0 is the initial population in the excited state, and Ai is the
normalized amplitude of the exponential component with
lifetime τi. Fluorescence lifetime signal from a biological
samplecontainingmultipleﬂuorophorescanbecomefurther
complicated. For multiple exponential lifetimes, the average
lifetime value is sometimes reported, given by τ =
n
i=1 Aiτi.
This lifetime information can be measured either by
time-domain or frequency-domain methods [20–22]. In the
time-domain technique, a pulsed excitation source is used to
excite the ﬂuorophore of interest in the biological sample.
The subsequent time proﬁle of the ﬂuorescence emission is
measured using time gating techniques. Figure 3 illustrates
the time-domain FLIM process. In frequency-domain FLIM,
an amplitude-modulated excitation source is employed. The
lifetime of the ﬂuorophore causes the emitted ﬂuorescence
signal to be modulated at the same frequency but with a
phase shift relative to the excitation light (see Figure 4).
Measurement of this phase oﬀset using phase-sensitive
detection (such as a lockin ampliﬁer) will then give the value
of the lifetime, τ, by the relation tanφ = ωτ,w h e r eφ is the
phase oﬀset, ω is the modulation frequency. If the lifetime
is multiexponential, it is necessary to measure the phase
oﬀset at several modulation frequencies in order to obtain
the diﬀerent lifetime components [23]. Some advantages of
the frequency-domain technique include faster acquisition
compared to the time-domain technique and insensitivity
to high photon count rates, which is a problem with time-
domain techniques as high count rates can skew the time
histogram to shorter times. Frequency-domain FLIM has
been recently demonstrated using an inexpensive ﬁeld-
programmable gate array and photon-counting detection
giving very rapid and highly sensitive measurements [24].
FLIM has found particular use in imaging NADH/
NAD(P)H. Bound and unbound NADH have diﬀerent
characteristic ﬂuorescence lifetimes (free NADH ∼0.3ns,
protein-bound NADH ∼2ns), and therefore FLIM can be
used to measure the ratios of these populations giving
an indication of metabolic activity and oxidative stress
[25–27]. For example, several studies have demonstrated
diﬀerences in NADH lifetime values between cancerous and
normal cells. FLIM is being actively researched for clinical
screening of the skin for distinguishing between dysplastic
nevi, melanoma, and other dermatological disorders [28–
30]. Recently, FLIM was employed to study the cornea using
autoﬂuorescence lifetime imaging [31]. In ophthalmological
applications, FLIM can be potentially utilized in studying
oxidative stress in particular due to interaction of tissue with
pharmacological agents or due to disease.
An additional multiphoton imaging technique that is
fundamentally diﬀerent from both ﬂuorescence and har-
monic generation is coherent anti-Stokes Raman Spec-
troscopy (CARS). CARS is a nonlinear version of Raman
spectroscopy. In the Raman process, a narrow-band laser
illuminatesthesample,andaportionoftheincidentphotons
are scattered by interactions with molecular vibrations,
resulting in a shift to higher (anti-Stokes) or lower frequency
(Stokes) photons. The signal intensity is very weak because
of the extremely low-scattering cross-section
(∼10−30 cm2/molecule) as opposed to the absorption cross-
section of a typical ﬂuorophore (∼10−15 cm2/molecule).
In contrast to traditional Raman spectroscopy, CARS is
a nonlinear optical process that selectively and coherently
excites vibrational resonances of biomolecules to rapidly
obtain the Raman (vibrational) spectrum. Compared to
traditional Raman scattering, the CARS process increases
the detection sensitivity by up to 107 to allow rapid dataJournal of Ophthalmology 5
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Figure 2: Schematic of elements of a multiphoton imaging optical setup. (a) Descanned detection whereby the emitted signal is collected
after travelling back through the scanning mirrors. (b) Nondescanned detection. DM indicates dichroic mirror.
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Figure 3: Illustration of the ﬂuorescence lifetime principle. The
short-pulsed excitation light (red) and the longer time duration
ﬂuorescence emission light (green) is shown as a function of time.
InFLIM,thetimescaleoftheﬂuorescence emission,τ,i sm e a s u r e d .
acquisition [32]. With the associated decrease in mea-
surement times, CARS has been applied in biomedical
microscopy toimage livecellsatvideo rateswithoutextrinsic
ﬂuorescence dye labeling [32–34]. Figure 1 illustrates the
CARS process. Two photons (pump and Stokes) excite a
speciﬁc vibrational resonance coherently. A third photon
(probe) subsequently measures the density of the vibrational
resonance. The number of emitted anti-Stokes photons that
areenergyshifted bythatvibrationalmodeis proportionalto
the square of the density of the vibrational oscillators, thus
yielding the molecular concentration of the target [35]. A
traditional CARS setup uses two synchronized picosecond
lasers or a single picosecond laser with an optical parametric
ampliﬁer to generate the two laser beams with diﬀerent
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Figure 4: Illustration of frequency-domain ﬂuorescence lifetime
measurement. The excitation light (red) is modulated in amplitude
at a frequency ω, while the ﬂuorescence light (blue) is emitted with
thesamemodulationfrequencybutwithaphaseshiftintime,φ.For
a single exponential lifetime, the value of the ﬂuorescence lifetime
is related by tanφ = ωτ.
frequencies matched to one particular vibrational resonance.
By tuning the laser frequency diﬀerence to a particular
vibrational mode, forexample, 2850cm−1 ofthe CH2 stretch
for lipids, chemical-speciﬁc imaging can be achieved all
withoutuseofendogenousdyesorotherlabelingtechniques.
CARS therefore has great potential clinical applications,
although it has not yet been applied to imaging in the eye.
2.4. Microendoscopy. Due to the limitations in the penetra-
tion depth, MPM has so far only been applied in the clinic
for screening of the skin [28, 37]. A major step towards
extending the applicability of MP imaging for clinically6 Journal of Ophthalmology
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Figure 5: Schematic of the eye highlighting the regions of interest
for imaging with multiphoton microscopy. Light path for imaging
of the retina through the anterior chamber and lens is shown.
relevant applications is the introduction of microendoscopy
for intrabody tissue imaging inaccessible to standard bulky
optics,[38–43].Developmentofmicroendoscopesorﬂexible
probesforMPimaging can greatlyimprovetheinstrumenta-
tion for clinical use in ophthalmology. Several demonstrated
research applications of microendoscopy include probing
of neural activity [39, 40, 44], blood ﬂow measurements
[38, 45], and imaging of goblet cells in gastric epithelium
[46]. Furthermore, clinical high-resolution microendoscopy
has been demonstrated to detect the extracellular matrix
proteins collagen and elastin in the human dermis [47, 48].
Imaging oftheeyeinanimal models usinga microendoscope
has been demonstrated by Wang et al. [18].
The introduction of compound gradient refractive index
(GRIN) lenses as focusing optics [44, 49, 50], double-
clad photonic crystal ﬁbers [51, 52] for superior detection
eﬃciency and mechanical ﬂexibility, and microelectrome-
chanical systems (MEMS) scanning mirrors [52–54]h a s
been among the most important technological advance-
ments towards microendoscopy. The majority of micro-
lenses used in nonlinear imaging, GRIN lenses, have a
typical size of 0.2–1mm in diameter, 1–10cm in length,
and a numerical aperture of less than 0.6. However, due to
low numerical aperture and optical aberration, the optical
Rayleigh resolution has been limited to ∼1μm in lateral
and ∼10μmi na x i a ld i r e c t i o n[ 39, 40]. Recently, aberration-
corrected, high-NA planoconvex lenses (NA < 0.85) acting
like micro-objectives have been reported to provide on-
axis resolution comparable to water-immersion objectives
[50]. With further advances, microendoscopy technology
can bring the full capabilities of MPM to clinical imaging.
2.5. Histology. Another clinical application of MPM is in
histology, where there is no requirement for deep tissue
penetrationasthetissuecaneasilybesectionedin10–100μm
thick slices. MPM can have advantages over traditional
histological staining techniques by providing more detailed
information and highlighting features without perturbing
the sample through processing. Preparation of samples for
both standard histological staining and electron microscopy
require chemical ﬁxation and dehydration with alcohols.
These treatments can cause artifacts and distortions within
the tissue due to infusion of ﬁxatives and shrinkage of
tissue due to alcohol treatment. In addition, changes to ﬁne
tissue morphology can occur with heat infusion of paraﬃn
(for histology) or with polymerization of resin (EM).
The application of MPM in histology can be immediately
implemented in the clinic and is greatly underutilized. There
are opportunities for the development of more accessible
MPM systems thatwould perform imaging ontissue samples
with automated analysis routines to aid physicians.
3.MultiphotonImaging ofthe Eye
3.1. Comparison of Multiphoton to Current Clinical Imaging
Modalities. Several groups have preformed MP imaging
of diﬀerent regions of the eye, ex vivo,i m p l i c a t e di na
variety of disease pathologies [31, 55–68]. These studies
show that MP imaging of the eye for clinical applications
has great promise. Current clinical techniques for imaging
include optical coherence tomography (OCT) and confocal
reﬂectance microscopy as well as ﬂuorescence imaging. In
comparison with MP imaging, OCT imaging has poorer
spatial resolution of 2–10μm lateral and therefore cannot
be used to reveal subcellular level structure. While confocal
reﬂectance microscopy does allow subcellular level resolu-
tion, its contrast mechanism is due to changes in index
of refraction, and therefore it does not have the functional
information inherent in MP imaging. Fluorescence imaging
uses exogenous dyes to stain the eye in a nonspeciﬁc manner
typically for looking at the vasculature in the retina. None
of these devices are capable of providing functional data for
imaged tissues and are thus limited in their ability to direct
or inﬂuence clinical decision making on a consistent basis.
3.2. Multiphoton Imaging of Eye Sections. Figure 5 shows
a diagram of the eye highlighting the regions of interest
for MPM studies. MP imaging of the cornea is of interest
for diagnosis of diseases such as corneal dystrophies and
endothelial dysfunction and has been reported by several
groups. Steven et al. demonstrated 2PAF, SHG, and aut-
oﬂuorescence lifetime imaging of diﬀerent ocular surface
pathologies on corneal tissue sections using a commercial
instrument for clinical MP imaging (DermaInspect, JenLab
GmbH, Neueng¨ onna, Germany) [31]. By performing multi-
ple wavelength excitation at 730nm and 835nm and resolv-
ing diﬀerent lifetime components by FLIM, they were able
to identify and distinguish between epithelial cells, goblet
cells, erythrocytes, macrophages, collagen, elastin, vascular
structures, and pigmented lesions. Aptel et al. demonstrated
SHG, 2PAF, and THG of corneal tissue sections and SHG
and 2PAF of the trabecular meshwork. In particular, they
demonstrated an additional contrastmechanism by selecting
either linear or circularly polarized excitation for THG [55].
Chen et al. demonstrated simultaneous reﬂectance confocal
microscopy, 2PAF, and SHG on corneal sections [56, 57].
Morishige et al. used three-dimensional SHG imaging to
characterize structural lamellar organization of the anteriorJournal of Ophthalmology 7
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Figure 6: Vascular bed of a human retina imaged by second harmonic generation (SHG). Serial z-sections, spaced 12μma p a r t ,o fah u m a n
retina are shown beginning with (a) through (f). The images shown are collected using the 800nm near infrared laser excitation with a
collection window of 390–410nm. The collagen structure of a large blood vessel is clearly visible through the series, which represents a
height of 60μm.
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Figure 7: Second harmonic generation (SHG) and two-photon autoﬂuorescence (2PAF) of TM region of a human eye from a 73-year-old
donor. A section of the eye was ﬂat-mounted with the anterior chamber facing the microscope objective. Images represent a projection of
the multiple z-sections ﬂattened into a single plane. (a) The SHG emission(388nm to 409nm) collected from 800nm excitation of TM. (b)
The 2PAF emission window (452nm to 644nm) collected simultaneously. (c) Merged image of SHG (blue) and AF (green) emission. Black
scale bar = 50μm. This ﬁgure is reprinted from [36].8 Journal of Ophthalmology
cornea [58]. Teng et al. demonstrated simultaneous SHG
and 2PAF imaging in an intact ex vivo porcine eye to
identify cellular components of the cornea, limbus, and
conjunctiva, as well as imaging corneal and scleral collagen
ﬁbers [59]. MP imaging of both cornea and retinal sections
was demonstrated by Wang et al. [60, 61].
MPimagingoftheretinahasalsobeendemonstratedand
may ﬁnd utility in detection of retinal pigment epithelium
(RPE) dysfunction and photoreceptor-related dystrophies.
To date, no imaging of the human retina has been per-
formed through the anterior chamber, although explants
of human retina and RPE have been imaged by the tissue
autoﬂuorescence [62–64]. There are additional diﬃculties
in imaging the retina for clinical applications due to the
optical constraints posed by the iris that eﬀectively limit
the numerical aperture. For example, for an iris opening of
8mm diameter and typical distance from iris to the retina of
17mm, the eﬀective numerical aperture, which is indicative
of the collection angle of the emitted optical signal, is given
by the equation NA = nsinθ ∼ 0.3, using the index of
refraction of water (n = 1.33). The numerical aperture
besides limiting the collection eﬃciency of the emitted signal
also limits how tightly the excitation light can be focused,
thus determining the achievable resolution of the image.
In addition, the aberrations in the lens of the eye can also
decrease the obtainable resolution in MP imaging. In order
toalleviatethisproblem,wavefrontcorrectionusingadaptive
optics has been performed for retinal imaging [65, 66].
To ourknowledge,MP imaging ofalivingretina/RPEhas
only been performed in a rodent eye by imaging through the
exterior sclera. In this instance, Imanishi et al. used MPM
to view the retina/RPE autoﬂuorescence as well as to localize
stores of the visual pigment retinal [67]. The retina itself
has no apparent SHG signal, although the overlying retinal
vasculature and underlying connective tissue can be imaged
via the collagen content. We have demonstrated this in our
lab on a Zeiss LSM510 multiphoton confocal microscope,
illustrated in Figure 6.I nFigure 6(c), one can see the top of
the blood vessel followed by the inside of the vessel as the
objective moves through the vascular bed. Further optical
sectioning past this point yields no further SHG signal.
Recently, we have demonstrated MP imaging of the
trabecular meshwork (TM) region of the eye using SHG
and 2PAF [68]. Imaging of the TM is important because
degenerationof the TM is implicated in glaucoma; therefore,
characterizing the cell and collagen structures in the TM
may allow early diagnosis, disease monitoring, as well as
fundamental studies of the disease mechanism. In our paper,
the TM was ﬂat-mounted and visually sectioned by 0.5μm
intervals to a depth of 50μm and then computer modeled
into a single-plane projection (Figure 7). SHG and 2PAF
emission windows were collected using the META spectral
detector on a Zeiss LSM510 multiphoton confocal system.
Figures 7(a) and 7(b) show the SHG and 2PAF ﬂuorescence,
respectively. Although the SHG signal is comparatively
weaker than the 2PAF, these two signals are qualitatively the
same when overlapped in Figure 7(c) (blue = SHG, green =
2PAF). Since collagen is the most common noncentrosym-
metric macromolecule in the TM, the SHG signal is highly
suggestive of the fact that the structures seen by 2PAF are in
fact collagen ﬁbers. In these images, the majority of collagen
ﬁbers of the TM appear as smooth bundles of between 10
and 20μm, although the occasional ∼1μm collagen ﬁber
is visible. These bundles have a fairly consistent diameter
over short distances but over longer distances (>250μm)
commonly split or join other bundles. The end result is a
meshwork of collagen interwoven with varying-sized regions
of nonﬂuorescent signal, which we assume to be ﬂuid spaces.
3.3. Transscleral Imaging. Issues for MPM use in the clinic
include accessibility of the diﬀerent regions of the eye to
optical light. Imaging of the trabecular meshwork using
MPM would be of great clinical value in particular for early
disease diagnosis and monitoring of glaucoma. However,
in order to access this region, it would be necessary to
image through approximately 600 microns of scleral tissue.
For transscleral imaging, in general, only the surface of
the sclera can be imaged as the highly scattering scleral
tissue greatly limits optical light transmission. Vogel et al.
measured the optical properties of human sclera using an
integrating sphere. They found a transmission of 6% at
442nm, 35% at 804nm, and 53% at 1064nm [69]. Although
the excitation light for MPM ranging from 800 to 1000nm
can likely penetrate the sclera, the shorter wavelength SHG
and autoﬂuorescence emission will be greatly reduced upon
collection in the epidirection. We continue to research this
known limitation of MPM for TM imaging and believe that
future advances will lead to greater clinical applicability of
this technology.
3.4. Power and Wavelength Requirements for In Vivo Imaging.
One of the advantages of MPM is the ability to use infrared
light illumination, which is much less phototoxic for the
eye than visible light. One issue with this technique for
clinical use is potential thermal mechanical damage to the
tissue during imaging due to absorption of the laser energy
and local heating eﬀects. Several studies have shown that
the thermal damage due to two-photon absorption in most
tissue under imaging conditions is negligible [70]. However,
there are potential damage issues associated with pigmented
tissue such as those found in the skin or the retina. There are
methods to mitigate this including reducing the repetition
rate of the laser to allow for thermal diﬀusion between
pulses on the same location in the tissue [71, 72]. The
pulse duration of the laser can also have a great impact on
thermaldamage.Duetal.foundareductionintissuedamage
threshold with pulse duration for the same total energy
delivered to the tissue sample [73]. The diﬀerences in laser
system parameters combined with diﬀerences in tissue type
suggest that, before any clinical use of MPM, photodamage
issues must be carefully characterized.
3.5. Drug Delivery Monitoring. Finally, one exciting future
application of MPM is in monitoring drug delivery in vivo.
Kek et al. applied two-photon microscopy to monitor the
transscleral delivery of tazarotenic acid using its intrinsic
ﬂuorescence at 500nm [74]. The emerging technique ofJournal of Ophthalmology 9
stimulated Raman scattering (SRS) a similar multiphoton
technique to CARS imaging also has great potential for drug
delivery monitoring because of its speciﬁcity; that is, the
generatedsignal isspeciﬁc toa singlechemical compound,as
well as the linear dependence of the signal on concentration
[75]. SRS has currently been applied to monitor penetration
of dimethyl sulfoxide (DMSO), a skin-penetration enhancer
and retinoic acid in the upper dermal layer. There are many
opportunities for applying SRS to monitoring drug delivery
in the eye due to the transparency of the tissue making
deeper penetration depths possible as compared to the
skin.
4.Conclusionand FutureProspects
Current imaging techniques, such as ultrasound and OCT,
have greatly inﬂuenced the standards of clinical and surgical
ophthalmic care. Physicians can now detect disease using
very sensitive imaging modalities and can also follow the
progression of disease, thus shedding light on the eﬃcacy
of applied interventions. While availability of ﬁne struc-
tural information is increasingly available in the clinical
setting, the actual function of the imaged structures remains
unknown. MPM oﬀers the potential for obtaining both
structural andfunctional dataona widerange ofophthalmic
tissues. For example, it may be possible to image the
trabecular meshwork structure while also establishing the
metabolism of individual trabecular meshwork cells by
quantifying NAD(P)H concentrations in real time. Such
information could lead to earlier and more precise disease
detection,whilealsoallowingformoreinsightintotheeﬀects
of therapeutic interventions aimed at preserving vision.
Future applicability of MPM in practice will require
further advances in the ability to penetrate past tissues,
such as sclera, that have high scattering properties. The
safety of using MPM also requires further studies since
some ocular tissues have high melanin content which may
lead to greater energy absorption and related tissue damage.
Another obstacle that will need to be addressed is the
diﬃculty in obtaining data across the relatively long axial
length distance noted between the surface of the cornea and
the posterior pole. Fortunately, advances in MPM continue
to develop at a rapid pace, and obstacles that existed in
the past have been overcome with continued research. With
continued advances, the application of MPM in ophthalmic
practice promises to yield valuable clinical information that
will ultimately result in improved patient care, which is the
common goal of researchers and physicians alike.
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